WeloxPharma stands out as a leading manufacturer of high-quality eye drops, delivering innovative ophthalmic solutions tailored to meet global healthcare standards. With a commitment to vision care and patient well-being, the company specializes in producing a wide range of eye drop formulations designed to treat conditions such as dry eyes, infections, allergies, and inflammation.
Each product is developed in state-of-the-art, GMP-certified facilities that ensure sterile production environments, consistent quality, and maximum efficacy. Backed by a team of pharmaceutical experts and advanced technologies, WeloxPharma consistently raises the bar in the eye care segment.
We have been rated as the best eye drops exporter in India because of quality and affordable price. Our prices compared to other eye drops exporters in India are very low without compromising the quality.
We are the most trusted eye drops Supplier in India that is because we ship our products on a provided time frame. Before dispatch, a double check is given by a quality team in India.
At WeloxPharma, we are committed to protecting and enhancing vision through the development of safe, effective, and high-quality ophthalmic solutions. As a reliable eye drop manufacturer in India, we focus on addressing a wide range of eye conditions—from dryness and irritation to infections and inflammation. Other than Eye Drops Weloxparma is also ear drops manufacturer supplier exporter in India with the best quality of products in resonable price.
Our mission is to deliver world-class eye care products that meet both national and international standards, improving eye health one drop at a time.
Manufacturing ophthalmic products demands high precision, strict hygiene, and sterile environments. At WeloxPharma, we follow a meticulous, science-backed production process:
India has become a global hub for affordable and quality pharmaceutical manufacturing and Weloxpharma is one of the best Pharmaceutical Manufacturer Company in Gujarat India—and eye drops form an essential part of this segment.
The Indian ophthalmic drug market, including eye drops, is valued at over USD 450 million and growing steadily.
The eye drop segment is expected to grow at a CAGR of over 6.5%, driven by rising eye health awareness, increased screen exposure, and affordability.
India exports ophthalmic formulations to over 60 countries, including the USA, Africa, and Southeast Asia.
Eye drops are regulated by the Central Drugs Standard Control Organization (CDSCO), ensuring global-quality compliance.
Innovation is at the core of WeloxPharma’s operations. Our dedicated R&D division constantly explores:
With a strong focus on patient-centric product design, we aim to stay ahead of evolving therapeutic needs in ophthalmology.